Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Heather W, Wickless"'
Publikováno v:
Journal of Medical Education and Curricular Development, Vol 2016, Iss 3, Pp 105-107 (2016)
Externí odkaz:
https://doaj.org/article/5c159602a34048ee8e20a3b993bcaf50
Autor:
Belén Rubio-González, Joan Guitart, Heather W. Wickless, Alba Posligua, Xiaolong Zhou, Kimberly A. Sable, Jaehyuk Choi, Maria Estela Martinez-Escala, Steven T. Rosen, Jason B. Kaplan, Audrey Rutherford, Christiane Querfeld, Barbara Pro
Publikováno v:
Journal of the American Academy of Dermatology. 78:1068-1076
Background Cutaneous lymphoma diagnosed after anti–tumor necrosis factor-α therapy (anti–TNF-α) has been reported in the literature, yet a clear link between both events remains elusive. Objective To review our experience with cutaneous lymphom
Publikováno v:
International Journal of Dermatology. 56:1400-1405
Background The utility of brentuximab vedotin (BV) in CD30+ systemic lymphomas is established, however evidence for treating primary cutaneous lymphoma remains limited. This study aimed to evaluate BV in treating CD30+ transformed mycosis fungoides (
Autor:
Yi Yang, Heather W. Wickless
Publikováno v:
Leukemia Research Reports, Vol 8, Iss C, Pp 14-18 (2017)
Leukemia Research Reports
Leukemia Research Reports
To determine some of the key clinical features that help prompt clinicians to pursue additional work-up for evaluation of CNS involvement of MF, we conducted a systematic review to better define characteristics, treatments, outcomes, and mortality in
Publikováno v:
Journal of the American Academy of Dermatology.
Autor:
Brian L. Scott, Heather W. Wickless
Publikováno v:
JAAD Case Reports
Romidepsin is a histone-deacetylase inhibitor administered for treatment-refractory mycosis fungoides. Common side effects include fatigue, weakness, nausea, and cytopenia. We report a patient with Sezary syndrome treated with romidepsin who develope
Publikováno v:
Journal of cosmetic dermatology. 17(2)
INTRODUCTION Patients often seek skin care recommendations from their dermatologist. The objective of this study was to determine the degree of education dermatology residents receive on skin care and cosmeceutical products, the source of education,
Publikováno v:
International journal of dermatology. 56(12)
The utility of brentuximab vedotin (BV) in CD30A literature review was conducted, and we analyzed data from published trials and case reports obtained via search of Ovid-MEDLINEMean age at BV initiation was 60.8 years (67 - PC-ALCL; 60.1 - MF), and 4
Autor:
Heather W. Wickless, Neeta Malviya
Publikováno v:
Hematology Reports
Hematology Reports, Vol 8, Iss 2 (2016)
Hematology Reports, Vol 8, Iss 2 (2016)
We report a case of primary cutaneous CD30+ post-transplant lymphoproliferative disorder with an uncommon finding of signet ring cell features in a heart transplant patient. The neoplastic cells were CD4 and CD30 positive, and negative for S-100, pan
Autor:
Ann Cameron Haley, Erika E. Reid, Heather W. Wickless, Maria L. Colavincenzo, Alfred Rademaker, Judy H. Borovicka, Dennis P. West
Publikováno v:
Journal of the American Academy of Dermatology. 66:e97-e102
Background Hair loss may significantly impact an individual's self-image, and studies indicate that patients with both clinically apparent and clinically imperceptible hair loss may have significantly decreased quality of life (QoL). Moreover, clinic